Product
Budesonide and Formoterol Fumarate Dehydrate (BF)
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A 12-Week, Randomized, Open-Label, Parallel-Group Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® (160/4.5 and 320/9 mcg) as Compared With SYMBICORT® TURBOHALER® (200/6 and 400/12 mcg) as Treatment for Adult Patients With Asthma (The Easy Low Instruction Over Time [ELIOT] Study)Status: Completed, Estimated PCD: 2015-03-13